Canada markets closed

enVVeno Medical Corporation (5HJ.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
4.4800-0.0400 (-0.88%)
At close: 08:01AM CEST
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
0
0
0
0
0
Operating Expenses
Research Development
13,040
13,583
9,914
5,728
4,252
Selling General and Administrative
10,904
11,655
15,018
11,165
4,883
Total Operating Expenses
23,944
25,238
24,932
16,893
9,135
Operating Income or Loss
-23,944
-25,238
-24,932
-16,893
-9,135
Interest Expense
5.982
-
-
-
-
Total Other Income/Expenses Net
1,634
1,542
102
346
-4.099
Income Before Tax
-22,116
-23,516
-24,669
-16,528
-9,135
Income from Continuing Operations
-22,116
-23,516
-24,669
-16,528
-9,135
Net Income
-22,116
-23,516
-24,669
-16,528
-9,135
Net Income available to common shareholders
-22,116
-23,516
-24,669
-16,528
-9,743
Basic EPS
-2.14
-
-2.20
-1.90
-7.54
Diluted EPS
-2.14
-
-2.20
-1.90
-7.54
Basic Average Shares
11,232
-
11,230
8,680
1,291
Diluted Average Shares
11,232
-
11,230
8,680
1,291